Literature DB >> 20890144

Invasive palliative interventions: when are they worth it and when are they not?

Florian Strasser1, David Blum, Daniel Bueche.   

Abstract

In palliative cancer care situations, invasive palliative interventions are frequently considered. The perception of invasiveness has a wide range and is subjective. A structured palliative care approach can guide decisional processes. It may contain 6 key elements: (1) multidimensional and multiprofessional assessment patients current priorities, (2) quality of current symptom management for the potential target intervention, (3) documentation of potential reasons to reduce symptomatic medications, (4) cautious judgment if patients' potential clinical benefit can be extrapolated from published evidence, (5) a decisional process for the considered intervention (e.g., the 7 P's model: priority, price, probability, prognosis, progression, prevention, preferences), and (6) agreement on the goal of the intervention before the invasive intervention. The examples of pleural effusion and parenteral nutrition are briefly emphasized. Oncologists may be competent to foster patients' participation in decision making and to use available specialist palliative care competencies and those of other professions.

Entities:  

Mesh:

Year:  2010        PMID: 20890144     DOI: 10.1097/PPO.0b013e3181f842b3

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  8 in total

1.  Dying of hematologic patients--treatment characteristics in a German University Hospital.

Authors:  Patrick Brück; Malgorzata Pierzchlewska; Marta Kaluzna-Oleksy; Maria Elizabeth Ramos Lopez; Mathias Rummel; Dieter Hoelzer; Angelika Böhme
Journal:  Support Care Cancer       Date:  2012-03-13       Impact factor: 3.603

2.  [In Process Citation].

Authors:  Dietmar Weixler
Journal:  Wien Med Wochenschr       Date:  2015-12

3.  [Is invasive therapy (medically/ethically) justifiable nearing an end of life situation, if it is based on symptom control and quality of life?].

Authors:  Stefanie Anna Schatz-Krienzer; Friedemann Nauck
Journal:  Wien Med Wochenschr       Date:  2014-08-12

4.  When is an invasive palliative intervention in an acute internal medical patient worth it? A structured palliative approach.

Authors:  Thomas Weber; Florian Strasser
Journal:  Wien Med Wochenschr       Date:  2015-11-30

5.  War and peace? The oncologic and the palliative care perspective on personalized cancer treatment in a patient with advanced cancer.

Authors:  Eva K Masel; Sophie Schur; Doris Posch; Dietmar Weixler; Johannes G Meran; Manuela Schmidinger; Herbert H Watzke
Journal:  Wien Klin Wochenschr       Date:  2015-05-19       Impact factor: 1.704

6.  Combination therapy with low-dose metolazone and furosemide: a "needleless" approach in managing refractory fluid overload in elderly renal failure patients under palliative care.

Authors:  Hon Wai Benjamin Cheng; Mau-Kwong Sham; Kwok-Ying Chan; Cho-Wing Li; Ho-Yan Au; Terence Yip
Journal:  Int Urol Nephrol       Date:  2014-05-14       Impact factor: 2.370

7.  Does special education in palliative medicine make a difference in end-of-life decision-making?

Authors:  Reetta P Piili; Juho T Lehto; Tiina Luukkaala; Heikki Hinkka; Pirkko-Liisa I Kellokumpu-Lehtinen
Journal:  BMC Palliat Care       Date:  2018-07-18       Impact factor: 3.234

8.  Kidney Function Worsening Is Linked to Parenteral-Nutrition-Dependent Survival in Palliative Care Patients.

Authors:  Lea Kum; Alexander Friedrich; Markus Kieler; Elias Meyer; Petar Popov; Paul Kössler; Anna Kitta; Feroniki Adamidis; Raimund Oberle; Eva Katharina Masel; Matthias Unseld
Journal:  Nutrients       Date:  2022-02-11       Impact factor: 5.717

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.